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ABSTRACT
Most genome-wide and transcriptome-wide association studies (GWAS, TWAS) focus
on European populations; however, these results cannot always be accurately applied to nonEuropean populations due to differences in genetic architecture. Using summary statistics from
GWAS in the Population Architecture using Genomics and Epidemiology (PAGE) study, which
comprises ~50,000 Hispanic/Latinos, African Americans, Asians, Native Hawaiians, and Native
Americans, we perform transcriptome-wide association studies to determine gene-trait
associations. Initially, we compared results using two transcriptome prediction models derived
from the Multi-Ethnic Study of Atherosclerosis (MESA) populations: the African American
(AFA) model and the Hispanic/Latino (HIS) model. We identified 141 unique genome-wide
significant trait-associated genes. 11 of the 141 gene-trait pairs were found to have colocalized
eQTL and GWAS signals and replicated in PhenomeXcan. Overall, we identified more
significant, colocalized, replicated gene-trait pairs in the HIS MESA model than the AFA model.
Since the largest population in PAGE is of Hispanic/Latino ancestries, TWAS with more
population-matched transcriptome models, i.e. HIS rather than AFA, have more power for
discovery and gene-trait replication.
Following this analysis, we then compared results using three larger transcriptome
prediction models derived from Multi-Ethnic Study of Atherosclerosis (MESA) populations: the
African American and Hispanic/Latino (AFHI) model, the European (EUR) model, and the

ix

African American, Hispanic/Latino, and European (ALL) model. We identified 240 unique
genome-wide significant trait-associated genes. We found more significant, colocalized genes
that replicate in larger cohorts when applying the AFHI model to the PAGE summary statistics
than the EUR or ALL model. We also found more significant gene-trait pairs using the AFHI,
which identified 152 trait-associated genes, when compared to the number of associations made
by both the AFA and HIS transcriptome models. Thus, TWAS with population-matched
transcriptome models have more power for discovery and replication, demonstrating the need for
more transcriptome studies in diverse populations.

x

INTRODUCTION
Genome-wide association studies
Among the global population of approximately 8 billion people, there are millions of
genetic variants that contribute to gene expression levels and complex traits despite our genomes
being 99.9% identical (Chial et al., 2008). Since the first human genome was sequenced back in
2003, there has been an explosion of individuals having their own DNA sequenced. As genomic
sequencing techniques are refined and mass amounts of data are collected, genome-wide
association studies are now an integral part of the study of complex diseases and traits. Genomewide association studies (GWAS) examine single nucleotide polymorphisms (SNPs) across the
genome for association with diseases and other complex traits. SNPs are instances in the genome
where there is a single nucleotide substitution at a specific position. GWAS methods have
identified thousands of SNPs associated with complex traits, despite most SNPs being found
outside the protein-coding regions of the gene, making it difficult to understand the biological
mechanisms behind the observed associations.
Since their development in 2007, GWAS have become increasingly popular as they are a
relatively simple method to identify SNP-level associations (Visscher et al., 2012). As of
September 9th, 2020, there are 4,694 publications and 197,708 associations included in the
GWAS Catalog, a database of GWAS results (Buniello et al., 2019; MacArthur et al., 2017).
GWAS results have contributed to the known biology of common diseases and complex traits
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despite GWAS’ experimental design being hypothesis-generating rather than hypothesis-driven
(Visscher et al., 2012).
Despite their growing popularity, GWAS are still limited by the speed at which they can
be performed and genotyping and sequencing technologies. GWAS genotype data is based on
chips analyzing SNPs. These are limited to 200,000-2,000,000 SNPs per chip due to price and
speed. Since only a limited number of SNPs can be tested on a chip, researchers must not only
design their experiment to capture as many independent SNPs as possible but also rely on LD
and imputation to infer missing portions (Moore et al., 2012; Marchini and Howie et al., 2010).
Therefore, rare SNPs are usually understudied in GWAS due to financial and time constraints.
The decision for which SNPs to test is also affected by which population is in question. If
genotyping an African population, it is important to use a chip with more SNPs as Africans have
higher genetic variation. African genomes have also had more time to recombine, leading to less
LD between alleles at different SNPs; therefore, more SNPs are needed to capture the variation
(Moore et al., 2012). This GWAS experimental strategy does not allow for rare genetic
variations or structural changes to be studied. However, as methods, such as whole exome
sequencing and whole genome sequencing, become more affordable, increasing the practice of
these methods may capture the rare variants and structural changes (Liu et al., 2017). Since the
proportion of discovered variants is dependent on sample size, an issue that is diminishing as
bio-bank size data and companies such as 23andMe have millions of samples at their disposal,
this experimental design flaw may be challenged (Visscher et al., 2012).
Along with the issue of deciding which SNPs to test, many SNPs in GWAS are located
outside of the protein-coding regions (Visscher et al., 2012). The SNP that is reported as the
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most significant variant from the GWAS may not be the functional variant due to LD (Moore et
al., 2012). There is also concern that over time, the entire genome will be associated with disease
predisposition and that most variant associations have no direct relationship to disease (Tam et
al., 2019). Without knowing the functional variant or gene, inferring actionability between the
GWAS tagged SNP and phenotype is unclear (Gamazon et al., 2015). Thus, many question the
reliability and quality of GWAS results.
Genetic diversity
Approximately 200,000 years ago, modern humans evolved and migrated to various parts
of the world as part of the “Out-of-Africa” evolutionary theory (Tishkoff et al., 2010; Campbell
and Tishkoff et al., 2010). As subgroups of the original population moved, they only brought a
small fraction of genetic variants from the group, thus, Africa is more genetically diverse in
comparison to the rest of the world due to this population bottleneck (Tishkoff et al., 2010;
Campbell and Tishkoff et al., 2010). According to the 1000 Genomes Project Phase 3 (1000G),
within the seven African (AFR) populations, there are, on average, 5 million variants per
genome. In comparison, the five European, five East Asian, and five South Asian population
genomes averaged 4-4.2 million variants (Consortium and The 1000 Genomes Project
Consortium et al., 2015). Some specific populations commonly contain what are otherwise
considered rare variants, a phenomena that can be attributed to the migration out of Africa and
thousands of years worth of genetic mutations (Consortium and The 1000 Genomes Project
Consortium et al., 2015). Through studying some of these specific, diverse populations,
researchers have identified millions of previously unknown variants, including mostly rare
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variants but also a few common variants, that are exclusive to one continental or major
geographical region (Bergström et al., 2020).
Ethnic disparities in GWAS
While GWAS have identified thousands of SNP-trait associations with complex traits, the
majority of the studies exclusively include individuals of European ancestries (Buniello et al.,
2019). As of 2017, within 4,655 GWAS, 78% of individuals are of European ancestries (Morales
et al., 2018), creating a significant gap of knowledge for those of non-European descent. Only
2.4% of individuals in GWAS are of African ancestries; however, they account for 7% of all
SNP-level associations made from those GWAS, likely caused by those individuals having more
genetic variation (Morales et al., 2018). As those of European ancestries only make up a small
fraction of the human population, expanding the number of non-European individuals in
genomic research benefits all populations by more fully incorporating global genetic diversity in
association studies. When attempting to predict disease risk based on European GWAS in
African populations, the results are skewed (Martin et al., 2020, 2017). Since populations were
isolated from each other by geography throughout large spans of human history, allele
frequencies and effect sizes differ across populations, making current GWAS results poor
genetic predictors for non-European populations (Martin et al., 2019). Since late 2014 “the
fraction of non-European individuals in GWAS has stagnated or declined” (Martin et al., 2019)
despite ongoing projects such as the National Institute of Health’s “All of Us” campaign,
23andMe’s “Global Genetics Project,” and Stanford University Morrison Institute’s Human
Genome Diversity Project (Cavalli-Sforza et al., 2005), which aim to increase diversity within
genomic data (Kaiser, Taylor, and Semple et al., 2016; Quelch and Rodriguez et al., 2016). In
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particular, the “All of Us” campaign emphasizes the need for underrepresented, diverse
populations to be included in genomic research in order to succeed in precision genomics and
eventually, precision medicine (Kaiser, Taylor, and Semple et al., 2016). To address this issue,
the Population Architecture using Genomics and Epidemiology (PAGE) study performed 28
GWAS on clinical and behavioral phenotypes in a multi-ancestries cohort that included
Hispanic/Latinos, African Americans, Asians, Native Hawaiians, and Native Americans (Wojcik
et al., 2019). The PAGE study is the largest collection of GWAS conducted in non-Europeans
with approximately 50,000 individuals in its cohort.
Within the PAGE study, they found that without including diverse populations in
genomic research, applying GWAS-based risk models in clinical care may worsen health
disparities (Wojcik et al., 2019). Current genomic databases underrepresent populations with the
greatest health burden, and as the world population becomes increasingly more complex, it will
also become increasingly more diverse (Wojcik et al., 2019), meaning the benefits to studying
diverse populations now will benefit current and future genetic predictors.
Transcriptome-wide association studies
Expression quantitative trait loci (eQTL)
Although GWAS associate thousands of genomic loci with complex traits, some
researchers claim that these results have been “disappointing in not explaining more genetic
variation in the population” (Visscher et al., 2012). GWAS results are difficult to interpret as
linkage disequilibrium (LD) shadows the causal variants and the causal genes regulated by those
variants are rarely determined from GWAS alone (Wainberg et al., 2019). Knowing the
statistical association of a SNP and a particular trait does not provide further information into the

6
biological mechanism at play nor the regulation of the trait. Most variants identified by GWAS
are located in noncoding regions of the genome, thus making it more difficult to identify the
functional importance in regards to the biology of complex traits (Buniello et al., 2019;
MacArthur et al., 2017; Huang et al., n.d.; McCarthy et al., 2008; Visscher et al., 2012).
Despite the number of loci found to be associated with traits in GWAS, understanding the
proportion of phenotypic variance explained for each locus potentially has more importance for
precision medicine (Shim et al., 2015). One way to incorporate functional genomics into GWAS
data is to study the regulatory elements that influence a gene’s transcriptional activity. This
transcriptional activity ultimately affects phenotypes (Li et al., 2018; Jung et al., 2020). Previous
studies have demonstrated how gene regulatory variants are commonly found in noncoding
regions of the genome. One such type of regulatory element is expression quantitative trait loci
(eQTLs) which are loci that explain a fraction of the variation in gene expression. These eQTLs
may aid in describing how regulated gene expression affects phenotypic variability in complex
traits (Gamazon et al., 2015). Of the thousands of SNP-level associations determined by GWAS,
many have large effect associations that can explain the heritable component of gene expression
traits. This genotypic data and gene expression data can be used to optimize a mathematical
model of the relationship when there are moderate sample sizes (Wheeler et al., 2016).
Gene-trait associations from gene expression
Going a step further from a traditional GWAS and identifying the mathematical model of
the relationship between genotype and gene expression data is called a transcriptome-wide
association study (TWAS). TWAS determines gene-trait level associations using gene
expression and phenotype data. This results in a more functional target than a single variant
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(Gamazon et al., 2015). TWAS methods such as PrediXcan (Gamazon et al., 2015) or FUSION
(Gusev et al., 2016) incorporate transcriptome data along with genotype and phenotype data to
make gene-trait associations (Gamazon et al., 2015; Gusev et al., 2016). In TWAS, cis-eQTL
genotype and gene expression datasets are used to build transcriptome models that predict gene
expression levels from genotypes. The models are integrated with GWAS data to test genes,
rather than SNPs, for association with complex traits. These transcriptome models can then be
used with other genotype datasets to calculate the predicted expression levels in other complex
traits. From there, gene-trait associations can be identified (Gamazon et al., 2015). Gene-trait
associations identified through TWAS provide evidence that gene regulatory mechanisms
underlie the trait’s biology (Gamazon et al., 2015). These results also provide information
allowing for the interpretability of the direction of effect of gene-trait associations.
PrediXcan uses the mathematical model Elastic Net (EN) to find the relationship between
genotype and transcriptome data. This EN model is a combination of L1 (LASSO) and L2
(Rigde) regularization of cis-eQTL effect sizes. Elastic-Net uses nested cross-validation to train
prediction models, estimate gene expression prediction weights, and calculate the coefficient of
determination between predicted and observed expression. This coefficient of determination acts
as our measure of prediction performance. From the pipeline output, gene predictors can be
quantified by the number of genes that are found significant by the model (Gamazon et al.,
2015).
Colocalization
Linkage disequilibrium (LD) is the non-random association of alleles at certain loci (Hill
and Robertson et al., 1968). When two alleles are in LD, the set of SNPs that are inherited
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together, or haplotypes, do not occur at the expected frequencies. The closer together two SNPs
are, the more likely it is that they will have higher levels of LD.
LD obscures the causal variants driving the GWAS association, making it difficult to
differentiate between causal SNPs. Colocalization is a technique to help differentiate between
causal and non-causal variants (Giambartolomei et al., 2014; Hormozdiari et al., 2016; Wen,
Pique-Regi, and Luca et al., 2017). Since TWAS relies on genotypic data, or even GWAS
summary statistics if using S-PrediXcan, LD affects the TWAS results, shadowing which causal
genes are driving the association. Therefore, colocalization techniques must also be applied to
TWAS results. These techniques use various statistical methods to calculate the overall
probability that that particular SNP/eQTL is the true causal SNP/eQTL. If the variants are both
contributing to gene expression, the QTL analysis from the GWAS data should almost
completely overlap with the predicted regulation association, suggesting colocalized signals. If
they are not both contributing to gene expression, the QTL analysis from the GWAS data should
not overlap with the predicted regulation association. Some of the most popular fine-mapping
and colocalization tools currently available are COLOC, eCAVIAR, and FASTENLOC
(Giambartolomei et al., 2014; Hormozdiari et al., 2016; Wen, Pique-Regi, and Luca et al.,
2017).
Disparities in genomic research limit colocalization methods
Other colocalization tools such as eCAVIAR and FASTENLOC are more statistically
rigorous than COLOC and allow for considering multiple causal variants; however, they require
LD correlation matrices and LD block information, respectively. LD patterns in non-European
populations are understudied and largely unknown due to limitations of sample size. LD is
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especially challenging in admixed populations due to tracts of ancestry arising from different
continental ancestors. If allele frequencies at the same loci are distinctly different, then LD
within admixed populations can even occur between alleles at locus pairs on different
chromosomes (Rybicki et al., 2001).
COLOC (Colocalisation Tests of Two Genetic Traits) is a colocalization technique that is
published as an R package in the R CRAN (Giambartolomei et al., 2014). COLOC uses an
Approximate Bayes Factor Model approach to colocalization and fits each variant to a linear
regression model. COLOC returns five posterior probabilities (P) for each of the two SNPs
tested. If the third posterior probability (P3) is large, then they conclude there are two
independent causal SNPs associated with each trait, suggesting independent signals. If the P4 is
large, then only a single variant is affecting both traits, indicating that the eQTL and GWAS
signals are colocalized. If P0 is large, neither SNP is in association with the trait
(Giambartolomei et al., 2014).
COLOC does not require providing further information on LD for the specific
population, which is especially advantageous when working with non-European, admixed
populations. COLOC looks at a single genomic region at a time with a major focus on
interpreting LD patterns at that particular loci; however, it assumes that there is only one causal
SNP (Giambartolomei et al., 2014). It is biologically known that multiple nearby SNPs can
contribute to a particular region’s expression. By only accounting for one causal SNP, COLOC
limits its ability to account for certain biological circumstances.
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Summary
In this thesis, we sought to identify more gene-trait associations in diverse populations
due to the ethnic disparities in genomic research. Previous genetic studies link SNPs to gene
expression as an intermediate to the phenotype in question, allowing for eQTL and
transcriptomic data along with genotypic data to predict gene expression through TWAS
methods. However, the majority of individuals included in both genomic and transcriptomic data
are European. By using existing genomic and transcriptomic data, we aim to expand the number
of gene-trait associations in non-European populations through TWAS.
With GWAS summary statistics and transcriptome prediction models, TWAS methods
such as S-PrediXcan can predict gene expression from genotypes. From S-PrediXcan output,
gene-trait associations are identified; however, due to linkage disequilibrium and the coregulation of genes affecting the results, we colocalize our TWAS results using COLOC
(Hormozdiari et al., 2016; Barbeira et al., 2018; Pividori et al., 2020; Giambartolomei et al.,
2014). This provides more evidence that the SNPs in discovered genes are acting through gene
expression regulation to affect the associated phenotypes. We then follow up our analysis by
looking for replication in large European TWAS through PhenomeXcan (Pividori et al 2020).
With these replicated genes, we identify potential biological mechanisms for various
phenotypes.

METHODS
Publication Disclaimer
This work was previously published in iScience (2020), 23(12),
doi.org/10.1016/j.isci.2020.101850 with the following authors:
Elyse Geoffroy¹, Isabelle Gregga², and Heather E. Wheeler¹, ²
¹Program in Bioinformatics, Loyola University, Chicago, IL, USA, ²Department of Biology,
Loyola University, Chicago, IL, USA
MESA transcriptome analysis
Phenotypic and genotypic data
The Population Architecture using Genomics and Epidemiology (PAGE) study
performed 28 GWAS analyzing different clinical and behavioral phenotypes in diverse
populations (Wojcik et al., 2019). We downloaded PAGE GWAS summary statistics from
https://www.ebi.ac.uk/gwas/publications/31217584. The PAGE cohort includes 22,216
Hispanic/Latino, 17,299 African American, 4,680 Asian, 3,940 Native Hawaiian, 652 Native
American, and 1,052 Other self-identified individuals (Wojcik et al., 2019).
Transcriptome prediction models
The Multi-Ethnic Study of Atherosclerosis (MESA) cohort includes individuals recruited
from six urban centers throughout the US: Baltimore, MD; Chicago, IL; Forsyth County, NC;
Los Angeles County, CA; northern Manhattan, NY; and St. Paul, MN. MESA individuals are
self-identified as “Black, African-American,” “White Caucasian,” and “Hispanic” (Bild et al.,
2002). The MESA transcriptome dataset comes from the monocytes of over 1,000 individuals
11
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(Liu et al., 2013). The genotypic data along with monocyte gene expression data from the MESA
study were previously used to create transcriptome prediction models (Mogil et al., 2018). The
models consist of protein coding genes with cross-validated R² > 0.01 and predictive
performance P < 0.05. In our first analysis, we used one transcriptome prediction model built
with data from individuals with African American ancestries (AFA, n = 233) and one model built
with data from Hispanic ancestries (HIS, n = 352). In our second analysis, we used one
transcriptome prediction model built with data from individuals with African American and
Hispanic ancestries (AFHI, n = 578), one model built with data from individuals with white
European ancestries (EUR, n = 585), and one model built with data from all populations
combined, individuals of African American, Hispanic, and European ancestries (ALL, n =
1,163). These gene expression prediction models were retrieved from http://predictdb.org/.
Transcriptome-based association studies
We used the software Summary-PrediXcan (S-PrediXcan) (Barbeira et al., 2018), an
extension of PrediXcan (Gamazon et al., 2015) that infers gene-trait associations using GWAS
summary statistics as input, to perform transcriptome-wide association studies (TWAS) of each
of the 28 PAGE phenotypes using the MESA gene expression prediction models. GWAS
summary statistics are the test statistics and p-values from GWAS rather than the genotype and
phenotype data.
In our initial S-PrediXcan study, we looked at the African American (AFA) MESA
transcriptome prediction model and the Hispanic (HIS) MESA transcriptome prediction models.
We considered S-PrediXcan genes significant if they met the threshold of P < 0.05/n, where n is
the number of genes in the transcriptome model tested in S-PrediXcan. AFA predicts the
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expression of 3,551 genes while HIS predicts the expression of 4,497 genes. The gene-trait pairs
that met this threshold were carried through to our colocalization analysis. To show some genes
meet a more conservative threshold, we applied a second, more conservative threshold to correct
for the total number of tests performed (P < 0.05/(28*3551 + 28*4497) = P < 2.2e-07).
However, the AFA and HIS MESA transcriptome models are limited by their sample
sizes and they each only represent a minority of the individuals’ ancestries in PAGE. To address
this issue, we then used the African American and Hispanic (AFHI) combined population
transcriptome prediction model as it best represents the genetic architecture of the majority of
individuals included in PAGE and its sample size is similar to the European (EUR) population
(Mogil et al., 2018; Wojcik et al., 2019). EUR does not include any overlapping individuals with
AFHI, and no individuals within PAGE are of European ancestries, providing an opportunity to
compare the prediction capabilities of population-matched and mismatched transcriptome
models. We also use the ALL MESA model due to its large sample size and its inclusion of all
MESA individuals (Mogil et al., 2018). We considered S-PrediXcan genes significant if they met
the threshold of P < 0.05/n, where n is the number of genes in the transcriptome model tested in
S-PrediXcan. AFHI predicts the expression of 5,557 genes while EUR predicts expression of
4,675 genes and ALL predicts expression of 6,218 genes. We carried gene-trait pairs that met
this threshold forward to colocalization analysis. Similarly to the first analysis, we also applied a
second threshold to correct for the total number of tests performed (P < 0.05/(5557*28 +
4675*28 + 6218*28) = P < 1.1e-07). This threshold is overly conservative since many of the
traits are correlated.
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Initially we do not account for the previous tests of AFHI, EUR, and ALL as we did not
directly compare the output of the analyses, and we focus on the AFHI subpopulations: AFA and
HIS. However, we do compare the TWAS discovery rates of AFHI, AFA, and HIS. In order to
compare these models, we applied the threshold (P < 0.05/(28*3551 + 28*4497 + 28*5557) = P
< 1.3e-07) to account for the total number of tests.
Colocalization analysis
We applied the software COLOC (Giambartolomei et al., 2014; Hormozdiari et al., 2016;
Barbeira et al., 2018; Pividori et al., 2020) to MESA eQTL summary statistics (Mogil et al.,
2018) and PAGE GWAS summary statistics (Wojcik et al., 2019) to identify if the eQTLs within
the gene prediction models and GWAS hits are colocalized. COLOC analyzes a single genomic
region at a time with a major focus on interpreting LD patterns at that particular locus, assuming
one causal variant (Giambartolomei et al., 2014; Hormozdiari et al., 2016; Barbeira et al., 2018;
Pividori et al., 2020). Only SNPs within the predictor models of significant genes from the SPrediXcan analyses were tested using COLOC.
COLOC returns five posterior probabilities (P) for each of the two SNPs tested. A P4
probability (P4 > 0.5) indicates that the eQTL and GWAS signals are likely colocalized while a
P3 probability > 0.5 suggests independent signals. P0, P1, and P2 values greater than 0.5
suggests an unknown association (Giambartolomei et al., 2014; Hormozdiari et al., 2016;
Barbeira et al., 2018; Pividori et al., 2020). To run COLOC with the PAGE GWAS and MESA
eQTL data, we used a pipeline developed by the Hae Kyung Im Lab
(https://github.com/hakyimlab/summary-gwas-imputation).
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LocusCompare figures
We generated LocusCompare figures using the R package ‘LocusComparer’ (Liu et al.,
2019), which takes eQTL and GWAS SNP data, specifically the SNP id and the respective pvalues, and plots the signal trends. It determines the lead SNP, labelled with the purple diamond,
by identifying the SNP with the lowest sum of p-values from the two studies. The linkage
disequilibrium (LD) r² values are taken from the 1000 Genomes populations. LD is especially
challenging in admixed populations due to tracts of ancestry arising from different continental
ancestors. For instance, one challenge of LD in admixed populations is that if allele frequencies
at the same loci are distinctly different, then LD may even transpire between alleles at locus pairs
on different chromosomes (Rybicki et al., 2002). For our analysis, we applied the admixed
American (AMR) 1000 Genomes population LD data with our AFHI MESA results and the EUR
1000 Genomes population LD data with our EUR MESA results.
Replication in larger European TWAS
PhenomeXcan, which can be found at http://apps.hakyimlab.org/phenomexcan, is a new
gene-based resource that includes S-MultiXcan, a cross-tissue TWAS method, results using the
Genotype-Tissue Expression Project (GTEx) version 8 tissue models and GWAS summary
statistics from the UK BioBank and other large European ancestries consortia (Pividori et al.,
2020; Barbeira et al., 2019).
We searched the PhenomeXcan database for the genes found significant in our SPrediXcan analyses. From there, we identified if any of the phenotypes for a particular
significant gene were related or identical phenotypes to those within the PAGE study (Wojcik et
al., 2019). We considered an S-PrediXcan gene-trait pair replicated if the gene-trait pair had P <
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0.0008 and the same direction of effect in PhenomeXcan. If there were multiple PhenomeXcan
results for the same gene-trait pair with conflicting directions of effect, we did not consider those
gene-trait pairs replicated.

MESA TRANSCRIPTOME PREDICTION RESULTS
Publication Disclaimer
This work was previously published in iScience (2020), 23(12),
doi.org/10.1016/j.isci.2020.101850 with the following authors:
Elyse Geoffroy¹, Isabelle Gregga², and Heather E. Wheeler¹, ²
¹Program in Bioinformatics, Loyola University, Chicago, IL, USA, ²Department of Biology,
Loyola University, Chicago, IL, USA
PAGE and MESA transcriptome prediction results
Here, we perform TWAS with S-PrediXcan (Barbeira et al., 2018) in PAGE using
GWAS summary statistics and five transcriptome prediction models built in the Multi-Ethnic
Study of Atherosclerosis (MESA) (Mogil et al., 2018). We compared performance and
replication of each transcriptome prediction model to determine whether population ancestry
matching or sample size is more important in TWAS. Initially, we use one transcriptome model
built in the African American (AFA) MESA population and one transcriptome model built in the
Hispanic/Latino (HIS) population. Following this analysis to study larger models’ impact, we
then use one transcriptome model built in the MESA African American and Hispanic/Latino
populations (AFHI), one built in the MESA European population (EUR), and another built in the
MESA African American, Hispanic/Latino, and European populations combined (ALL). From
there, we colocalize our S-PrediXcan results using COLOC (Giambartolomei et al., 2014;
Hormozdiari et al., 2016; Barbeira et al., 2018; Pividori et al., 2020) to provide more evidence
that the SNPs in discovered genes are acting through gene expression regulation to affect the
17
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associated phenotypes. We then test our discovered associations for replication using the
PhenomeXcan database, which includes S-MultiXcan results from large, predominantly
European GWAS (Barbiera et al., 2019; Pividori et al., 2020). We find a higher proportion of
gene-trait pairs identified in PAGE replicate when we use the population-matched AFHI
transcriptome prediction model than either the EUR or ALL transcriptome prediction models.
All scripts used for analyses are available at
https://github.com/WheelerLab/MESA_expression_prediction.
We sought to perform TWAS in the Population Architecture using Genomics and
Epidemiology (PAGE) study (Wojcik et al., 2019) to reveal new associations or show that
previously discovered GWAS loci likely act through transcription regulation to affect the trait. In
the PAGE study, 28 GWAS on clinical and behavioral phenotypes (Table 1) were executed
(Wojcik et al., 2019). Individuals in PAGE self-identified as Hispanic/Latino (n = 22,216),
African American (n = 17,299), Asian (n = 4,680), Native Hawaiian (n = 3,940), Native
American (n = 652) or Other (n = 1,052) (Wojcik et al., 2019). In comparison to any other
GWAS, this study includes the most phenotypes tested in a single study, the most trait
associations, and the highest number of non-European individuals (Wojcik et al., 2019). TWAS
integrate genetically regulated gene expression into complex trait mapping studies, but like
GWAS, most are performed in European populations (Gamazon et al., 2015; Gusev et al., 2016).
We compared S-PrediXcan results using transcriptome prediction models trained with genotype
and monocyte gene expression data from three populations in MESA to find genes associated
with traits in PAGE. The two largest populations included in PAGE are Hispanic/Latino and
African American. By using the MESA HIS (n = 352), which comprises individuals of
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Hispanic/Latino ancestries, and MESA AFA (n = 233), which comprises individuals of African
American ancestries, population-matched transcriptome prediction models, we aim to identify
more potential causal genes and to compare the performance and replication rate of these two
transcriptome models in TWAS with the PAGE GWAS summary statistics. We also sought to
compare TWAS results in the diverse PAGE cohort using two different transcriptome prediction
models, one built in populations that more closely match the genetic ancestries of PAGE and one
that is composed of individuals of European genetic ancestries. In addition, we compared these
results to a third transcriptome model that included all available populations.
Larger population-matched transcriptome models identify more significant gene-trait pairs
After applying S-PrediXcan with the 28 PAGE GWAS summary statistics (Table 1) and
the AFA and HIS MESA transcriptome models to perform TWAS, we identified 77 significant
gene-trait pairs with the AFA transcriptome prediction model and 110 significant gene-trait pairs
with the HIS transcriptome prediction model (P < 0.05/n, where n is the number of genes tested
for association with each trait) within 15 of the 28 PAGE phenotypes. In total, we identified 141
unique significant gene-trait pairs. The Z-scores of the AFA and HIS (Figure 1) identified genes
that are highly correlated (R = 0.88). This high Z-score correlation remains when all tested
genes, not just those that reached significance within one of the models, are compared (R =
0.97). When we applied a more stringent threshold, to account for the total number of tests (P <
2.2e-07), we identify 15 significant gene-trait pairs using AFA and 26 significant gene-trait pairs
using HIS (Figure 2). However, this threshold is overly conservative as many of the traits are
related.
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Table 1. Population Architecture using Genomics and Epidemiology (PAGE) phenotypes tested
in TWAS and the significant gene counts for each phenotype and transcriptome prediction
model.
Trait

Total N
or N
cases/ N
controls

Mean
or %
cases

SD of
Mean

Number of
significant
genes
identified in
TWAS with
AFHI
transcriptome
models

Number of
significant
genes
identified in
TWAS with
EUR
transcriptom
e models

Number of
significant
genes
identified in
TWAS with
ALL
transcriptom
e models

Inflammatory
Traits
C-reactive
protein (CRP)
(mg/L)

28,520

4.114

4.836

9

8

9

White blood cell
(WBC) count
(109cells/L)

28,608

6.253

1.943

78

34

91

Mean
corpuscular
hemoglobin
concentration
(MCHC) (g/dL)

19,803

32.909

1.249

1

2

2

Platelets (per
mcL)

29,328 246.783

64.273

4

4

3

HDL cholesterol
(mg/dl)¹

33,063

50.738

15.372

11

5

12

LDL cholesterol
(mg/dl)¹

32,221 137.777

40.945

4

5

3

Triglycerides
(mg/dl)¹

33,096 137.830

92.125

9

9

15

Lipid Traits
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Total
Cholesterol
(mg/dl)¹

33,185 214.864

46.452

9

7

11

Lifestyle Traits
Cigarettes/day
exclude
nonsmokers

15,862

12.507

9.088

0

0

0

Coffee
(cups/day)

35,902

0.893

1.130

0

0

0

HbA1c
(mmol/mol)2

11,178

36.823

4.520

0

0

0

Fasting insulin
(pmol/L)2

21,551

10.233

7.979

0

0

0

Fasting glucose
(mmol/L)2

23,911

5.050

0.633

1

1

0

Type 2 Diabetes
(cases/controls)

14,042/
31,683

30.7%

1

0

2

30.580

3

3

3

89.023

9.596

0

1

2

17,422 158.909

22.364

3

1

2

35,433 132.150

22.243

0

0

0

Glycemic Traits

Electrocardiogra
m Traits
QT interval (ms)
QRS interval
(ms)
PR interval (ms)

17,348 410.678
17,046

Blood Pressure
Traits
Systolic blood
pressure (mm
Hg)¹
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Diastolic blood
pressure (mm
Hg)¹

35,433

80.681

Hypertension
(cases / controls)

27,123/
22,018

55.2%

24,838

0.855

9,066

WHR

33,904

13.827

0

0

0

0

0

0

0.082

0

0

0

0.952

0.066

0

0

0

NA

NA

0

0

0

Height (cm)

49,796 163.893

9.568

19

11

21

BMI (kg/m2)

49,335

29.333

6.285

0

0

0

Chronic kidney
disease
(cases/controls)

4,154 /
41,573

10.0%

0

0

0

End stage renal
disease
(cases/controls)

602 /
32,459

1.9%

0

0

0

eGFR
(mL/min)³

27,900

90.548

0

0

0

Anthropometric
Traits
WHRFemales2
WHR-Males2

Kidney Traits

21.880

Phenotype information and GWAS sample sizes were taken from Supplementary Table 1 in
Wojcik et al.,. 2019. Wojcik et al., 2019 had a combined Nmax = 49,839. 1Traits have been
adjusted for medications by adding a constant. 2Traits have been adjusted for BMI. ³Estimated
glomerular filtration rate (eGFR) was calculated using the CKD-EPI (Chronic Kidney Disease
Epidemiology Collaboration) formula from (Levey et al., 2009). See Wojcik et al., 2019 for
details.
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Figure 1. Z-score comparison of TWAS significant genes identified by HIS and AFA MESA
transcriptome prediction models in PAGE. Gene-trait pairs that were identified as significant (P
< 0.05/n, n = the number of genes in the transcriptome model tested in S-PrediXcan) by either
model are displayed. The Pearson correlation of displayed gene-trait pairs is shown in the upper
left corner (R=0.88).
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Figure 2. Manhattan plot of the 15 of 28 PAGE phenotypes tested that returned significant
TWAS gene-trait pairs using the AFA and HIS MESA gene expression prediction models. Each
point represents the -log10(p) of a gene association test and gene chromosomal position colored
by phenotype. Only significant gene-trait pairs are shown (P < 0.05/n, n = the number of genes in
the transcriptome model tested in S-PrediXcan). The dotted line is at the more conservative
significance threshold calculated using all tests (P < 2.2e-07). Using the AFA and HIS models,
we identified 15 and 26 significant gene-trait pairs, respectively, at this threshold. Gene-trait
pairs with P < 1e-50 are displayed at P = 1e-50 for readability.
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Larger transcriptome model identifies more colocalized genes
Because linkage disequilibrium (LD) and gene co-regulation are potential confounders of
TWAS results (Giambartolomei et al., 2014; Hormozdiari et al., 2016; Barbeira et al., 2018;
Pividori et al., 2020; Gamazon et al., 2015; Wainberg et al., 2019), we further investigated
whether the TWAS gene associations had colocalized signals with known eQTLs. Colocalization
provides additional evidence that the SNPs in a given expression model are functioning via gene
expression regulation to affect the associated trait (Giambartolomei et al., 2014; Hormozdiari et
al., 2016; Barbeira et al., 2018; Pividori et al., 2020). We applied COLOC (Giambartolomei et
al., 2014) with the PAGE GWAS summary statistics and the AFA and HIS MESA eQTL data
(Mogil et al., 2018). For each of the eQTL MESA datasets, only SNPs included in both the
eQTL dataset and the GWAS summary statistics were tested. This allows us to determine if
eQTLs are shared between the gene expression prediction models and the GWAS results.
In our S-PrediXcan analysis, we identified 77 and 110 significant gene-trait pairs using
the AFA and HIS MESA transcriptome prediction models, respectively. Of these gene-trait pairs,
15 AFA gene-trait pairs (19%) and 27 HIS gene-trait pairs (25%) had a colocalization probability
P4 > 0.5, suggesting the eQTL and GWAS signals are colocalized. Overall, we identified 34
unique AFA and HIS-discovered gene-trait pairs with colocalized eQTL and GWAS signals. 46
AFA gene-trait pairs and 53 HIS gene-trait pairs were found to be independent (P3 > 0.5) while
COLOC could not confirm 16 AFA gene-trait pairs and 29 HIS gene-trait pairs as either
colocalized or independent signals (P3 < 0.5 and P4 < 0.5). It is unknown whether these genes
are contributing to their respective traits through gene expression regulation with current data
and colocalization methods.
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More HIS-discovered gene-trait pairs replicated in PhenomeXcan than AFA-discovered
gene-trait pairs
To determine if the gene associations we identified in PAGE replicated in TWAS studies
of larger European populations, we used PhenomeXcan, a gene-trait association resource
(Pividori et al., 2020). PhenomeXcan is a gene-based resource with the S-MultiXcan cross-tissue
gene-trait association results from UK BioBank GWAS Summary Statistics, other accessible
large-scale GWAS, and the Genotype-Tissue Expression Project (GTEx) version 8 models
(Pividori et al., 2020; GTEx Consortium, 2020).
We tested the 34 unique colocalized gene-trait pairs for replication in the PhenomeXcan
database. We included genes with P < 0.0015 (Bonferroni correction for 34 tests) and the same
direction of effect with the same or similar trait as the discovery in PAGE (Table 5). If a gene
meets both of these requirements, we consider it to have replicated in the larger, European
populations. Of the 15 AFA colocalized discoveries, 3 (20%) replicated in PhenomeXcan while
11 of the 27 HIS colocalized discoveries replicated in PhenomeXcan (41%). Significant genetrait pairs BAK1 with platelet count, PGP with height, SETD9 with height, and UBE2Z with
height replicated in both MESA models. In our previous analysis BAK1 with platelet count was
also found significant in AFHI, EUR, and ALL TWAS and replicated in PhenomeXcan.
PhenomeXcan also reports the FASTENLOC calculated regional colocalization
probabilities (RCP) that are greater than 0.1. Given the conservative nature of colocalization
approaches, this threshold limits reporting of false negatives (Pividori et al., 2020). Of the genetrait pairs tested that had RCP values listed in PhenomeXcan, all had a RCP > 0.5. This RCP
value provides strong evidence that these genes are colocalized, and therefore, contributing to the
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trait through gene expression regulation. These genes are ZBTB38, SETD9, SLC22A4, SMIM19,
BAK1, and CREB5.
Table 2: AFA and HIS identified S-PrediXcan significant genes in PAGE with colocalization
probability (P4) > 0.5 that replicated in independent studies in PhenomeXcan.
Gene
Name

chr

BAK1

6

BAK1

6

BAK1

6

BAK1

6

CETP

16

CREB5

7

CREB5

7

CREB5

7

ISCA2

Phenotype Model

Effect
Size

Zscore

P

P3

P4

AFA
AFA

-14.57 -11.37 6.2E-30 0.01 0.99

1.0E-320

0.74

HIS

-11.24 -10.01 1.3E-23 0.02 0.98

2.6E-149

0.97

HIS

-11.24 -10.01 1.3E-23 0.02 0.98

1.0E-320

0.74

HIS

-6.62

-18.93 6.0E-80 0.00 1.00

6.1E-97

NA

HIS

-0.04

-5.77 7.8E-09 0.03 0.94

5.0E-71

1.00

HIS

-0.04

-5.77 7.8E-09 0.03 0.94

5.4E-54

1.00

HIS

-0.04

-5.77 7.8E-09 0.03 0.94

1.2E-67

1.00

14

Platelet
count
Platelet
count
Platelet
count
Platelet
count
HDL
cholesterol
WBC
count
WBC
count
WBC
count
Height

PhenomeX RCP
can Pvalue
-14.57 -11.37 6.2E-30 0.01 0.99 2.6E-149 0.97

HIS

0.17

5.17

2.4E-07 0.06 0.94

1.1E-11

NA

ISCA2

14

Height

HIS

0.17

5.17

2.4E-07 0.06 0.94

5.8E-25

NA

PGAP3

17

HIS

-1.04

-4.50 6.8E-06 0.28 0.71

4.8E-04

NA

PGP

16

HDL
cholesterol
Height

AFA

-0.09

-4.55 5.3E-06 0.02 0.94

5.2E-20

NA

PGP

16

Height

AFA

-0.09

-4.55 5.3E-06 0.02 0.94

5.5E-15

NA

PGP

16

Height

AFA

-0.09

-4.55 5.3E-06 0.02 0.94

1.9E-32

NA

PGP

16

Height

HIS

-0.05

-5.31 1.1E-07 0.00 1.00

5.2E-20

NA

PGP

16

Height

HIS

-0.05

-5.31 1.1E-07 0.00 1.00

5.5E-15

NA

PGP

16

Height

HIS

-0.05

-5.31 1.1E-07 0.00 1.00

1.9E-32

NA

SETD9

5

Height

AFA

0.02

4.75

8.9E-08

0.55

2.0E-06 0.17 0.83
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SETD9

5

Height

AFA

0.02

4.75

2.0E-06 0.17 0.83

1.4E-09

0.52

SETD9

5

Height

AFA

0.02

4.75

2.0E-06 0.17 0.83

9.6E-17

0.61

SETD9

5

Height

HIS

0.02

4.46

8.1E-06 0.19 0.80

8.9E-08

0.55

SETD9

5

Height

HIS

0.02

4.46

8.1E-06 0.19 0.80

1.4E-09

0.52

SETD9

5

Height

HIS

0.02

4.46

8.1E-06 0.19 0.80

9.6E-17

0.61

SLC22A4

5

Height

HIS

-0.06

-4.66 3.2E-06 0.10 0.89

2.3E-23

0.54

SLC22A4

5

Height

HIS

-0.06

-4.66 3.2E-06 0.10 0.89

1.5E-15

NA

SLC22A4

5

Height

HIS

-0.06

-4.66 3.2E-06 0.10 0.89

6.2E-47

NA

SMIM19

8

MCHC

HIS

-0.11

-6.25 4.0E-10 0.02 0.98

2.8E-23

0.62

UBE2Z

17

Height

AFA

0.11

4.78

1.7E-06 0.28 0.56

4.1E-18

NA

UBE2Z

17

Height

AFA

0.11

4.78

1.7E-06 0.28 0.56

1.2E-25

NA

UBE2Z

17

Height

AFA

0.11

4.78

1.7E-06 0.28 0.56

4.5E-48

NA

UBE2Z

17

Height

HIS

0.10

5.58

2.5E-08 0.30 0.70

4.1E-18

NA

UBE2Z

17

Height

HIS

0.10

5.58

2.5E-08 0.30 0.70

1.2E-25

NA

UBE2Z

17

Height

HIS

0.10

5.58

2.5E-08 0.30 0.70

4.5E-48

NA

ZBTB38

3

Height

HIS

0.17

5.13

2.9E-07 0.04 0.95

1.3E-103

0.71

ZBTB38

3

Height

HIS

0.17

5.13

2.9E-07 0.04 0.95

9.5E-150

0.60

ZBTB38

3

Height

HIS

0.17

5.13

2.9E-07 0.04 0.95

1.9E-283

NA

P = P value calculated by S-PrediXcan; P3 = COLOC probability eQTL and GWAS signals are
independent; P4 = COLOC probability eQTL and GWAS signals are colocalized.
Of the 11 unique gene-trait pairs that replicated in PhenomeXcan, 4 of these gene-trait
pairs do not appear in the GWAS Catalog and thus may present new biology discovered through
TWAS. These gene-trait pairs are ISCA2, SETD9, SLC22A4, all associated with height, and
PGAP3 associated with HDL cholesterol. SETD9 was significant in AFA and HIS S-PrediXcan
while ISCA2, SLC22A4, and PGAP3 were significant in only HIS S-PrediXcan.
The other 7 gene-trait pairs which replicated in PhenomeXcan were found significant in
at least one other GWAS of the same or similar phenotype. In the original PAGE GWAS, BAK1
in relation to platelet count, CETP in relation to HDL cholesterol, ZBTB38 in relation to height,
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and SMIM19 in relation to mean corpuscular hemoglobin concentration (MCHC) were all
mapped as genes nearest to the significantly associated SNP (Table 6).
Table 3: AFA and HIS PhenomeXcan Replicated Gene-Trait Pairs Supported by Previous
GWAS.
Gene
Name
BAK1

Phenotype

Model

GWAS

Platelet
count

AFA,
HIS

CETP

HDL
cholesterol

HIS

CREB5

WBC
count
Height
HDL
cholesterol

HIS

Astle WJ et al., 2016, Oh JH et al., 2014, Li J et al., 2012,
Wojcik GL et al., 2019, Kanai M et al., 2018, Guo MH et
al., 2016, Chen MH et al., 2020
Hiura Y et al., 2009, Saxena R et al., 2007, Ko A et al.,
2014, Moore CB et al., 2015, Ridker PM et al., 2009,
Blackburn NB et al., 2018, Hebbar P et al., 2018, Smith
EN et al., 2010, Kurano M et al., 2016, Sabatti C et al.,
2008, Chambers JC et al., 2008, Heid IM et al., 2008,
Weissglas-Volkov D et al., 2013, Kraja AT et al., 2011,
Kathiresan S et al., 2008, Wu Y et al., 2013, Below JE et
al., 2016, Keller M et al., 2013, Andaleon A et al., 2018,
Peloso GM et al., 2014, Aulchenko YS et al., 2008, Kim
YJ et al., 2011, Willer CJ et al., 2008, Coram MA et al.,
2013, Zhou L et al., 2013, Wakil SM et al., 2016, Willems
EL et al., 2019, Gurdasani D et al., 2019, Southam L et al.,
2017, Kathiresan S et al., 2008, Waterworth DM et al.,
2010, Oh SW et al., 2020, Bandesh K et al., 2019, Deek R
et al., 2019, Middelberg RP et al., 2011, Lettre G et al.,
2011, Zemunik T et al., 2009, Lutz MW et al., 2019,
Proust C et al., 2015, Tabassum R et al., 2019, Kamatani Y
et al., 2010, Lu X et al., 2015, Andaleon A et al., 2019,
Nishida Y et al., 2019, Ligthart S et al., 2016, Nagy R et
al., 2017, Teslovich TM et al., 2010, Moon S et al., 2019,
Willer CJ et al., 2013, Spracklen CN et al., 2017, Surakka
I et al., 2015, Hoffmann TJ et al., 2018, He L et al., 2016,
Kanai M et al., 2018, Klarin D et al., 2018, Wojcik GL et
al., 2019, Noordam R et al., 2019, de Vries et al., 2019,
Bentley AR et al., 2019, Postmus I et al., 2016,
Kilpeläinen TO et al., 2019, Richardson TG et al., 2020,
Tuteja S et al., 2018, Ligthart S et al., 2016
Astle WJ et al., 2016, Chen MH et al., 2020

HIS
HIS

Novel
Novel

ISCA2
PGAP3

30
PGP
SETD9

Height
Height

SLC22A4
SMIM19

Height
MCHC

UBE2Z

Height

ZBTB38

Height

HIS
AFA,
HIS
HIS
HIS
AFA,
HIS
HIS

Tachmazidou I et al., 2017, Akiyama M et al., 2019
Novel
Novel
Hodonsky CJ et al., 2017, Wojcik GL et al., 2019, Astle
WJ et al., 2016, Chen MH et al., 2020
Akiyama M et al., 2019
Sanna S et al., 2008, Cho YS et al., 2009, Kim JJ et al.,
2009, Wojcik GL et al., 2019, Lettre G et al., 2008,
Weedon MN et al., 2008, Okada et al., 2010, Soranzo N et
al., 2009, Gudbjartsson DF et al., 2008, Bernt SI et al.,
2013, Wood AR et al., 2014, N'Diaye A et al., 2011, Nagy
R et al., 2017, He M et al., 2014, Lango Allen H et al.,
2010, Tachmazidou I et al., 2017, Akiyama M et al., 2019,
Kichaev G et al., 2018, Li D et al., 2020, Yang XL et al.,
2019

GWAS = list of GWAS Catalog publications with results that replicate this gene-trait pair.
TWAS identifies more significant genes when using larger and population-matched gene
expression prediction models
After our initial analysis of AFA and HIS MESA results, we then used S-PrediXcan with
the summary statistics from the 28 PAGE GWAS and the AFHI, EUR, and ALL MESA
transcriptome prediction models to perform TWAS. We found 14 of the 28 different PAGE
phenotypes returned significant gene-trait associations (Table 1). We identified 152 significant
gene-trait pairs with the AFHI transcriptome prediction model, 91 significant gene-trait pairs
with the EUR transcriptome prediction model, and 176 significant gene-trait pairs with the ALL
transcriptome prediction model (P < 0.05/n, where n is the number of genes tested for association
with each trait, Figure 3). With the AFHI MESA model, we identified more significant gene-trait
pairs than the 141 unique gene-trait pairs identified by the AFA and HIS MESA models. In total,
we identified 206 unique genes and 240 unique gene-trait pairs. Of the 240 unique gene-trait
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pairs, we found 50 using all three MESA models, 53 using both AFHI and EUR MESA models,
63 using AFHI and ALL MESA models, 13 using EUR and ALL MESA models, and 57
overlapped with gene-trait pairs previously mapped as a nearby gene to SNPs discovered in the
original PAGE GWAS (Wojcik et al., 2019).
The Z-scores of the AFHI and EUR identified genes that are highly correlated (R = 0.63);
indicating that most genes have similar effects across population models and just miss reaching
the significance threshold in one population or the other (Figure 4). This Z-score correlation
remains when all tested genes, not just those that reached significance with one population
model, are compared (R = 0.69). If we are more conservative in our TWAS multiple testing
adjustment and correct for all tests performed, not just tests within a trait, 95 gene-trait pairs
remain significant with AFHI, 46 gene-trait pairs with EUR, and 121 gene-trait pairs with ALL
(P < 1.1e-07, Figure 5).

Figure 3. The number of significant TWAS-discovered gene-trait pairs for AFHI, EUR, and ALL MESA
transcriptome prediction models with PAGE phenotypes. 14 of 28 phenotypes returned significant TWAS traitassociated genes. Significance was determined by P < 0.05/n (n = the number of genes in the transcriptome model
tested in S-PrediXcan).
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Figure 4. Z-score comparison of TWAS significant genes identified by AFHI and EUR MESA
transcriptome prediction models in PAGE. Gene-trait pairs that were identified as significant (P
< 0.05/n, n = the number of genes in the transcriptome model tested in S-PrediXcan) by either
model are displayed. The Pearson correlation of displayed gene-trait pairs is shown in the upper
left corner (R=0.63).
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Figure 5. Manhattan plot of the 14 of 28 PAGE phenotypes tested that returned significant
TWAS gene-trait pairs using the AFHI, EUR, and ALL MESA gene expression prediction
models. Each point represents the -log10(p) of a gene association test and gene chromosomal
position colored by phenotype. Only significant gene-trait pairs are shown (P < 0.05/n, n = the
number of genes in the transcriptome model tested in S-PrediXcan). The dotted line is at the
more conservative significance threshold calculated using all tests (P < 1.1e-07). 11 phenotypes
have gene associations that meet this more stringent threshold. Using the AFHI, ALL, and EUR
models, we identified 95, 121, and 46 significant gene-trait pairs, respectively, at this threshold.
Gene-trait pairs with P < 1e-50 are displayed at P = 1e-50 for readability.

Colocalization of TWAS results identifies SNPs most likely to act through gene expression
regulation
Across all TWAS phenotypes, white blood cell (WBC) count had the highest number of
significant genes for each transcriptome model. We identified 34 genes (91% on chromosome 1)
significantly associated with WBC count using EUR models, 78 genes (96% on chromosome 1)
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using AFHI models, and 91 genes (99% on chromosome 1) using ALL models. Like the
previous analysis of AFA and HIS S-PrediXcan results, we must account for the potential
confounders of TWAS results: linkage disequilibrium and gene co-regulation (Giambartolomei
et al., 2014; Hormozdiari et al., 2016; Barbeira et al., 2018; Pividori et al., 2020; Gamazon et al.,
2015; Wainberg et al., 2019). We applied COLOC (Giambartolomei et al., 2014) with the PAGE
GWAS summary statistics and the AFHI, EUR, and ALL MESA eQTL data (Mogil et al., 2018).
Only the SNPs that were included in the MESA model of interest and the GWAS summary
statistics were tested. In our S-PrediXcan analyses, we identified 152, 91, and 176 genome-wide
significant gene-trait pairs using the AFHI, EUR, and ALL models, respectively. Of these genetrait pairs, 32 AFHI gene-trait pairs, 20 EUR gene-trait pairs, and 37 ALL gene-trait pairs had a
colocalization probability P4 > 0.5, suggesting the eQTL and GWAS signals are colocalized. Six
of the gene-trait pairs were significant in all three (AFHI, EUR, and ALL) analyses. 13 gene-trait
pairs were significant in only the AFHI and ALL analyses while another three gene-trait pairs
were significant in the EUR and ALL analyses. 228 gene-trait pairs between AFHI, EUR, and
ALL (70, 60, and 98 gene-trait pairs, respectively) were found to be independent (P3 > 0.5).
However, COLOC could not confirm 50, 11, and 41 gene-trait pairs as either colocalized or
independent signals (P3 < 0.5 and P4 < 0.5) in the AFHI, EUR, and ALL models, respectively.
Whether these genes are contributing to their respective traits through gene expression regulation
is unknown with current data and colocalization models (Figure 7).
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Figure 6. SMIM19 GWAS and eQTL signals are colocalized in AFHI, but not EUR.
LocusCompare (Liu et al., 2019) plots for mean corpuscular hemoglobin concentration (MCHC)
PAGE GWAS p-values compared to (A) AFHI MESA eQTL p-values and (B) EUR MESA
eQTL p-values. When most points located on the diagonal, it indicates the GWAS and eQTL
signals are likely colocalized. The lead SNP in the AFHI eQTL and PAGE GWAS, rs2923403, is
located among the top signals, supporting the COLOC evidence for colocalization AFHI
(P4=0.90). When using EUR eQTL data in COLOC, the GWAS and eQTL signals did not
colocalize (EUR P4=0.047). Points are colored according to the pairwise LD r2 with rs2923403
in (A) AMR and (B) EUR 1000 Genomes populations.
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Figure 7. MESA Transcriptome Prediction Model and PAGE COLOC Results. More gene-height
pairs were found to be colocalized (P4 > 0.5) than gene-WBC count pairs despite more gene-trait
pairs being identified with WBC count in S-PrediXcan. Genes with unknown signal were found
to be neither colocalized nor independent (P3 < 0.5 and P4 < 0.5). COLOC could not confirm 50
AFHI-discovered significant gene-trait pairs.
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More AFHI-discovered gene-trait pairs replicate in PhenomeXcan than EUR- or ALLdiscovered gene-trait pairs
To look at whether the colocalized, significant gene-trait pairs we identified from our
TWAS replicate in a larger European population TWAS, we consider PhenomeXcan (Pividori et
al., 2020). We tested the 62 unique colocalized gene-trait pairs for replication in the
PhenomeXcan database, which includes results from larger European TWAS. We considered
PhenomeXcan genes with P < 0.0008 (Bonferroni correction for 62 tests) and the same direction
of effect with the same or similar trait as the discovery in PAGE to have replicated. Of the 32
AFHI colocalized discoveries, 11 (0.34) replicated in PhenomeXcan, of the 20 EUR discoveries,
5 (0.25) replicated in PhenomeXcan, and of the 37 ALL colocalized discoveries, 10 (0.27)
replicated in PhenomeXcan with the same direction of effect (P < 0.0008). Two of the
PhenomeXcan replicated gene-trait pairs, BAK1 with platelet count and SLC22A4 with height,
were significant in the AFHI, EUR, and ALL TWAS.
PhenomeXcan reports RCP values for each gene in their database if the RCP is greater
than 0.1. (Pividori et al., 2020). When looking at the gene-trait pairs that replicated in
PhenomeXcan, all gene-trait pairs had at least one study with an RCP > 0.5, which provides
strong evidence that these genes are colocalized and contributing to the trait through gene
expression regulation (Table 5).
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Table 4. AFHI, EUR, and ALL identified S-PrediXcan significant genes in PAGE with
colocalization probability (P4) > 0.5 that replicated in independent studies in PhenomeXcan.
Gene
Name

Zscore

Eff- P
ect
Size

CETP
TMEM2
58

-18

-12

4.2E
-73

-17

1.7E
-06

11

-4.8

5

4.7

-9.7

2.3E
-06

-7.7

5.7E
-06

3

4.5

17

5.4

9.4

2.7E
-08

0.09

1.3E
-06

14

4.84

5

-5.0

5.3E
-0.05 -07
0.16

3.1E
-11

8

-6.6

6

0.02

2.6E
-30

-0.06

6.0E
-06

11

-4.5

1

9.7

3.9E
-0.05 -22
-0.11

1.2E
-06

3

4.9

16

-2.6

8.0E
-07

SETD9
RASA2
UBE2Z
ISCA2
SLC22A
4
SMIM19
BAK1

chr

-11

CBL
VPS45
ZBTB38
PGP
-4.9

16

P3

2.3E03

P4

Model

Phenotype

AFHI

HDL
cholesterol

6.1E-97

HDL
cholesterol

1.6E-06

NA

9.6E-17

0.57

1

7.1E03 0.95

AFHI
AFHI

0.19

AFHI

0.77

0.03

0.97

0.10

0.90

AFHI
4.4E03

NA

Height
Height

NA
NA

5.8E-25
AFHI

0.81

Height

4.5E-48
AFHI

0.17

NA

2.1E-105
AFHI

0.23

RCP

Height

0.80

6.5E02 0.92

Best
PhenomeXcan P

AFHI
1

1.8E02 0.98

AFHI

2.2E02 0.95

AFHI

1.7E02 0.98

EUR

6.7E03 0.99

EUR

Height
6.2E-47

NA

2.8E-23

0.58

Platelet
count

2.6E-149

0.97

Platelet
count

6.9E-60

0.81

5.8E-06

NA

MCHC

WBC count
Height
9.53E-150 0.58
Height

NA
1.9E-32
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SLC22A
4

9.8E
-06

5

0.08

6

-12

0.08

2.8E
-32

0.11

1.4E
-06

12

-5.7

6

-12

-13

7.0E34

0.74

6.7E14

6

7.5

16

-20

4.2E-7.7
73
-3.7

1.4E12

16

-7.1

16

-4.5

5.6E-0.04 06
0.02

4.3E06

5

4.6
SLC20A
2

8

-4.5

7.9E-0.25 06

SLC22A
4

-0.05

2.4E06

5

-4.7

1

8.8

1.2E0.08 18
0.18

2.6E11

3

6.7

-4.4

BAK1
GPR84
BAK1
c6orf1
CETP
NLRC5
PGP
SETD9

VPS45
ZBTB38

4.8E02 0.95

EUR

2.5E03

EUR
1

Platelet
count

3.3E03

EUR
1

Platelet
count

3.9E-47

Platelet
count

2.6E-149

0.97

9.0E-132

NA

HDL
cholesterol

6.1E-97

NA

HDL
cholesterol

2.0E-65

NA

1.9E-32

NA

9.6E-17

0.57

7.3E-21

0.51

6.2E-47

NA

5.8E-06

NA

9.5E-150

0.58

3.9E03

ALL
1

0.21

0.54

ALL
2.3E03

ALL
1

0.31

0.66

ALL
1.3E02 0.95

ALL
ALL

0.19
0.32

0.68

0.10

0.89

ALL
ALL
ALL

NA

2.6E-149

0.97
NA

Height
Height
MCHC
Height
WBC count

0.69

8.3E03 0.99

6.2E-47

Height

0.80
ALL

0.27

Height

Height

P = P value calculated by S-PrediXcan; P3 = COLOC probability eQTL and GWAS signals are
independent; P4 = COLOC probability eQTL and GWAS signals are colocalized.
One gene that was identified as significantly associated with MCHC in both AFHI and
EUR at the stringent threshold of 1.1e-07 was SMIM19. In the PAGE GWAS, SNPs near
SMIM19 were found to be associated with MCHC (Wojcik et al., 2019). In our analysis,
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SMIM19 was only found to have colocalized GWAS and eQTL signals with AFHI eQTLs (P4 =
0.90) and HIS eQTLs (P4 top= 0.98), but not with AFA (P4 = 0.42), EUR (P4 = 0.047), or ALL
(P4 = 0.052) eQTLs (Figure 5). SMIM19 is also significantly associated with MCHC (P = 2.81e23, RCP = 0.578) in PhenomeXcan with GWAS summary statistics from the UKBioBank. A
gene located next to SMIM19 on chromosome 8, SLC20A2, associated with MCHC and had
colocalized signal with the ALL MESA eQTLs (P4 = 0.68). SLC20A2 is also significantly
associated with MCHC (P=7.28e-21, RCP = 0.507) in PhenomeXcan with GWAS summary
statistics from the UKBioBank. While both genes may be involved in MCHC, in our study,
SMIM19 has stronger evidence of acting through gene expression regulation to affect MCHC
than SLC20A2 as indicated by higher P4 in PAGE using AFHI, higher cross-validated prediction
performance in all populations, and higher RCP in PhenomeXcan.
Of the 17 unique gene-trait pairs that replicated in PhenomeXcan, 5 of these gene-trait
pairs do not appear in the GWAS Catalog and thus may represent new biology discovered
through TWAS. These include ISCA2, SETD9, and SLC22A4, associated with height; VPS45
associated with WBC count; and GPR84 associated with platelet count. ISCA2, SETD9,
SLC22A4, and VPS45 were significant in AFHI S-PrediXcan while only SLC22A4 and GPR84
were significant in EUR S-PrediXcan. SETD9, SLC22A4, and VPS45 were significant in ALL SPrediXcan.
The other 12 gene-trait pairs that replicated in PhenomeXcan were found significant in at
least one other GWAS of the same or similar phenotype. In the original PAGE GWAS, BAK1 in
relation to platelet count, CETP in relation to HDL cholesterol, c6orf1 in relation to height,
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ZBTB38 in relation to height, and SMIM19 in relation to MCHC were all mapped as genes
nearest to the significantly associated SNP (Table 6).
Table 5. AFHI, EUR, and ALL PhenomeXcan Replicated Gene-Trait Pairs Supported by
Previous GWAS.
Gene
Name

BAK1
CBL

CETP

c6orf1

Phenotype Model
AFHI,
Platelet
ALL,
count
EUR
Platelet
count
AFHI

GWAS
Astle WJ et al., 2016, Oh JH et al., 2014, Li J et al., 2012,
Wojcik GL et al., 2019, Kanai M et al., 2018, Guo MH et al.,
2016, Chen MH et al., 2020
Gieger C et al., 2011, Kanai M et al., 2018, and Astle WJ et
al., 2016, Chen MH et al., 2020
Hiura Y et al., 2009, Saxena R et al., 2007, Ko A et al., 2014,
Moore CB et al., 2015, Ridker PM et al., 2009, Blackburn
NB et al., 2018, Hebbar P et al., 2018, Smith EN et al., 2010,
Kurano M et al., 2016, Sabatti C et al., 2008, Chambers JC et
al., 2008, Heid IM et al., 2008, Weissglas-Volkov D et al.,
2013, Kraja AT et al., 2011, Kathiresan S et al., 2008, Wu Y
et al., 2013, Below JE et al., 2016, Keller M et al., 2013,
Andaleon A et al., 2018, Peloso GM et al., 2014, Aulchenko
YS et al., 2008, Kim YJ et al., 2011, Willer CJ et al., 2008,
Coram MA et al., 2013, Zhou L et al., 2013, Wakil SM et al.,
2016, Willems EL et al., 2019, Gurdasani D et al., 2019,
Southam L et al., 2017, Kathiresan S et al., 2008, Waterworth
DM et al., 2010, Oh SW et al., 2020, Bandesh K et al., 2019,
Deek R et al., 2019, Middelberg RP et al., 2011, Lettre G et
al., 2011, Zemunik T et al., 2009, Lutz MW et al., 2019,
Proust C et al., 2015, Tabassum R et al., 2019, Kamatani Y et
al., 2010, Lu X et al., 2015, Andaleon A et al., 2019, Nishida
Y et al., 2019, Ligthart S et al., 2016, Nagy R et al., 2017,
Teslovich TM et al., 2010, Moon S et al., 2019, Willer CJ et
al., 2013, Spracklen CN et al., 2017, Surakka I et al., 2015,
Hoffmann TJ et al., 2018, He L et al., 2016, Kanai M et al.,
2018, Klarin D et al., 2018, Wojcik GL et al., 2019, Noordam
R et al., 2019, de Vries et al., 2019, Bentley AR et al., 2019,
Postmus I et al., 2016, Kilpeläinen TO et al., 2019,
HDL
AFHI, Richardson TG et al., 2020, Tuteja S et al., 2018, Ligthart S
cholesterol ALL
et al., 2016
Cho YS et al., 2009, Kim JJ et al., 2009, Nagy R et al., 2017,
Wojcik GL et al., 2019, He M et al., 2014, Akiyama M et al.,
Height
ALL
2019
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Platelet
GPR84
count
EUR
Novel
ISCA2
Height
AFHI Novel
HDL
NLRC5
cholesterol ALL
Noordam R et al., 2019
ALL,
PGP
Height
EUR
Tachmazidou I et al., 2017, Akiyama M et al., 2019
RASA2
Height
AFHI Tachmazidou I et al., 2017, Kichaev G et al., 2018
AFHI,
SETD9
Height
ALL
Novel
Chen MH et al., 2020, Kanai M et al., 2018, Astle WJ et al.,
SLC20A2 MCHC
ALL
2016
AFHI,
ALL,
SLC22A4 Height
EUR
Novel
Hodonsky CJ et al., 2017, Wojcik GL et al., 2019, Astle WJ
SMIM19 MCHC
AFHI et al., 2016, Chen MH et al., 2020
HDL
Klarin et al., 2018, Hoffmann TJ et al., 2018, Surakka I et al.,
TMEM258 cholesterol AFHI 2015, Spracklen CN I et al., 2017,
AFHI,
UBE2Z
Height
ALL
Akiyama M et al., 2019
WBC
AFHI,
VPS45
count
ALL
Novel
Sanna S et al., 2008, Cho YS et al., 2009, Kim JJ et al., 2009,
Wojcik GL et al., 2019, Lettre G et al., 2008, Weedon MN et
al., 2008, Okada et al., 2010, Soranzo N et al., 2009,
Gudbjartsson DF et al., 2008, Bernt SI et al., 2013, Wood AR
et al., 2014, N'Diaye A et al., 2011, Nagy R et al., 2017, He
M et al., 2014, Lango Allen H et al., 2010, Tachmazidou I et
ALL,
al., 2017, Akiyama M et al., 2019, Kichaev G et al., 2018, Li
ZBTB38 Height
EUR
D et al., 2020, Yang XL et al., 2019
GWAS = list of GWAS Catalog publications with results that replicate this gene-trait pair.
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Larger transcriptome prediction model increases TWAS discovery and replication
Here we applied two MESA transcriptome predictions models: AFA and HIS, with the
GWAS results of the 28 PAGE study traits in S-PrediXcan. We performed this initial analysis
with the AFA and HIS models as PAGE mainly consists of African American and Hispanic
ancestries. Here we find that the HIS model outperformed AFA as AFA identified 77 significant
gene-trait pairs while HIS identified 110 gene-trait pairs. In this analysis, we found that the zscores are consistent between AFA and HIS (R=0.88) (Figure 4). This strong gene effect size
correlation demonstrates that the underlying biological pathways affecting each complex trait do
not differ between these two populations (Stranger et al., 2012; Marigorta and Navarro et al.,
2013; Wojcik et al., 2019; Shang et al., 2020). Therefore, our power to detect the associations
differ and the predictive power between the AFA and HIS populations is reduced (Mogil et al.,
2018; Martin et al., 2019; Keys et al., 2020). Four gene-trait pairs that replicated in
PhenomeXcan mapped as the nearest gene to an associated SNP locus in the original PAGE
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study (Wojcik et al., 2019). These include BAK1, where here we found increased predicted
BAK1 associated with decreased platelet count using both transcriptome models. We identified
CETP, SMIM19, and ZBTB38 using the HIS transcriptome model. Increased predicted CETP
associated with decreased HDL cholesterol levels, supporting previous findings (Barter et al.,
2003; Thompson et al., 2003; de Grooth et al., 2004; Kosmas et al., 2016; Andaleon, Mogil and
Wheeler et al., 2019). Increased predicted SMIM19 expression associated with decreased
MCHC. In addition to associating in the original PAGE GWAS, SNPs near SMIM19 associated
with MCHC in two independent GWAS (Hodonsky et al., 2017; Astle et al., 2016). Meanwhile,
we found increased predicted ZBTB38 expression associated with increased height. This
association is supported by 17 other independent GWAS (Gudbjartsson et al., 2008; Lettre et
al., 2008; Sanna et al., 2008; Weedon et al., 2008; Cho et al., 2009; Soranzo et al., 2009;
Kamatani et al., 2010; Kim et al., 2010; Lango Allen et al., 2010; N’Diaye et al., 2011; Bernt et
al., 2013; Wood et al., 2014; He et al., 2015; Nagy et al., 2017; Tachmazidou et al., 2017;
Kichaev, 2018; Akiyama et al., 2019; Wojcik et al., 2019).
Although not identified in the original PAGE GWAS (Wojcik et al., 2019), SNPs near
PGP associated with height in European and Japanese GWAS (Tachmazidou et al., 2017;
Akiyama et al., 2019). We found increased PGP predicted expression associated with decreased
height, thus providing more evidence that PGP affects height through gene expression
regulation. Similarly, despite not being identified in the original PAGE GWAS but was found to
have replicated in PhenomeXcan, SNPs near CREB5 associated with WBC count in two previous
independent GWAS (Astle et al., 2016; Chen MH et al., 2020). We found that increased CREB5
expression is related to decreased WBC count using the HIS MESA model.
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In summary, we found more gene-trait pairs discovered in PAGE with HIS transcriptome
models replicated in PhenomeXcan (11/27, 41%) in comparison to the AFA discovered genetrait pairs (3/15, 20%). Since the largest population in PAGE is of Hispanic/Latino ancestries,
TWAS with more population-matched transcriptome models, i.e. HIS rather than AFA, have
more power for discovery and gene-trait replication.
Population-matched transcriptome prediction increases TWAS discovery and replication
rate
Following the analysis of the AFA and HIS MESA transcriptome models in S-PrediXcan
with the PAGE GWAS results, we then looked at the larger MESA population models. We
applied S-PrediXcan to GWAS results of 28 traits from the PAGE study and found a higher
proportion of genes with colocalized GWAS and eQTL signals that replicated in PhenomeXcan
using the AFHI transcriptome models than with using EUR or ALL models. This suggests that
through population-matched gene expression prediction models, we find more significant genetrait pairs that replicate in larger, independent studies. We found that S-PrediXcan Z-scores are
consistent between AFHI and EUR transcriptome models (R=0.63), even if a particular gene was
only found significant using one or the other population (Figure 1). As has been shown in SNP
effect size comparisons (Stranger et al., 2012; Marigorta and Navarro et al., 2013; Wojcik et al.,
2019; Shang et al., 2020), this strong gene effect size correlation indicates the underlying
biological pathways affecting each complex trait do not differ between populations. Instead, our
power to detect the associations differs and subsequently, predictive power between populations
is reduced (Mogil et al., 2018; Martin et al., 2019; Keys et al., 2020). We have more power to
detect associations in PAGE that replicate in independent cohorts using the AFHI transcriptome
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prediction model because the minor allele frequency and LD structure of AFHI more closely
resembles that of PAGE than does the structure of either EUR or ALL (Mogil et al., 2018;
Wojcik et al., 2019).

Figure 8. Comparison of TWAS discovery rate and power between AFHI and AFA and HIS
MESA transcriptome prediction models in PAGE. A.) Upset plot of the number of significant
genes identified by each MESA transcriptome prediction model. Gene-trait pairs that were
identified as significant (P < 1.3e-07). 24 of the significant genes were identified by all three
MESA models while AFA uniquely identified 11 gene-trait pairs, HIS uniquely identified 21
gene-trait pairs, and AFHI uniquely identified 38 gene-trait pairs. Only 9 of the 28 phenotypes
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returned significant genes at this threshold. B.) Z-score comparison of TWAS significant genes
identified by AFHI and AFA. The Pearson correlation of displayed gene-trait pairs is shown in
the upper left corner (R = 0.98). C.) Z-score comparison of TWAS significant genes identified by
AFHI and HIS. The Pearson correlation of displayed gene-trait pairs is shown in the upper left
corner (R = 0.95). Gene-trait pairs found significant by either model are displayed.
Like our previous analysis of AFA and HIS-discovered significant, colocalized, and
PhenomeXcan replicated gene-trait pairs, the same four gene-trait pairs mapped as the nearest
gene to an associated SNP locus in the original PAGE GWAS (Wojcik et al., 2019). These
include BAK1 which was identified using all three transcriptome models, CETP using the ALL
and AFHI models, SMIM19 using the AFHI transcriptome model, and ZBTB38 using the EUR
and ALL transcriptome models. Increased predicted CETP associated with decreased HDL
cholesterol levels, supporting previous findings (Barter et al., 2003; Thompson et al., 2003; de
Grooth et al., 2004; Kosmas et al., 2016; Andaleon, Mogil and Wheeler et al., 2019). Increased
predicted SMIM19 expression associated with decreased MCHC. In addition to associating in the
original PAGE GWAS, SNPs near SMIM19 associated with MCHC in two independent GWAS
(Hodonsky et al., 2017; Astle et al., 2016). Meanwhile, we found increased predicted ZBTB38
expression associated with increased height. This association is supported by 17 other
independent GWAS (Gudbjartsson et al., 2008; Lettre et al., 2008; Sanna et al., 2008; Weedon
et al., 2008; Cho et al., 2009; Soranzo et al., 2009; Kamatani et al., 2010; Kim et al., 2010;
Lango Allen et al., 2010; N’Diaye et al., 2011; Bernt et al., 2013; Wood et al., 2014; He et al.,
2015; Nagy et al., 2017; Tachmazidou et al., 2017; Kichaev, 2018; Akiyama et al., 2019; Wojcik
et al., 2019). As mentioned previously, although not identified in the original PAGE GWAS
(Wojcik et al., 2019), SNPs near PGP were found to be associated with height in other previous
GWAS (Tachmazidou et al., 2017; Akiyama et al., 2019). In this study, we found increased PGP
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predicted expression associated with decreased height, thus providing more evidence PGP
affects height through gene expression regulation. Similar to PGP, SLC20A2 was not identified
in the original PAGE GWAS but replicated in PhenomeXcan. We found SNPs near SLC20A2
associated with MCHC in independent GWAS (Kanai et al., 2018), and SNPs near SLC20A2
were also associated with mean corpuscular hemoglobin volume, a related phenotype to MCHC,
in three other independent GWAS (Astle WJ et al., 2016; Kanai et al., 2018; Chen et al., 2020).
Here, we found increased SLC20A2 predicted expression associated with decreased MCHC.
More work is needed to disentangle whether SMIM19 or SLC20A2, which are located next to
each other on chromosome 8, is causal for MCHC. In our study, SMIM19 has stronger evidence
of acting through gene expression regulation to affect MCHC, but both genes may be involved.
We discovered several gene-trait associations that replicated in PhenomeXcan but were
not previously included in the GWAS Catalog and thus may represent new biological
mechanisms underlying the traits. These include ISCA2, SETD9, SLC22A4, VPS45, and GPR84.
Neither ISCA2 nor SETD9 were previously identified in GWAS as associated with height; we
found increased expression of these genes associated with increased height. SLC22A4 was not
previously identified as associated with height despite our findings demonstrating increased
SLC22A4 expression is associated with decreased height. Similarly, no previous GWAS have
linked increased GPR84 expression to increased platelet count. Mutations in VPS45 are known to
cause neutrophil defect syndrome (Vilboux et al., 2013; Stepensky et al., 2013), and we found
significant associations between predicted VPS45 expression and WBC count.
There are significantly more genes with no evidence of colocalization nor evidence of
independence when analyzing the AFHI S-PrediXcan output in comparison to the ALL or EUR
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S-PrediXcan output. These 50 genes could be functioning through gene expression regulation.
Better methods, specifically colocalization methods for recently admixed populations, are needed
to determine whether these genes are likely functional.
In summary, we found more gene-trait pairs discovered in PAGE with AFHI
transcriptome models replicated in PhenomeXcan (11/32, 34%) compared to the gene-trait pairs
discovered with EUR models (5/20, 25%) and, to a smaller extent, ALL models (10/37, 27%).
Since the largest populations in PAGE are of Hispanic/Latino and African American ancestries,
TWAS with population-matched transcriptome models, i.e. AFHI rather than EUR, have more
power for discovery and discovered genes are more likely to replicate. Transcriptome prediction
models trained in a cohort with similar ancestries to the original GWAS should be used and thus
more transcriptome studies in diverse populations are needed.
Conclusion
Here we identified gene-trait pairs using MESA transcriptome models in conjunction
with the PAGE GWAS summary statistics in a TWAS analysis. PAGE includes approximately
50,000 non-European individuals, thus making it the largest non-European GWAS, and
examines 28 phenotypes. The MESA models were trained using monocyte transcriptomes and
other tissues are likely more relevant to the phenotypes studied. Limitations for this study arose
as better complex trait methods for handling linkage disequilibrium and local ancestry in
admixed populations like PAGE and MESA are needed. In both MESA and PAGE, the
individuals were asked to self-identify with a provided list of race/ethnicity classifications.
However, these self-identification classifications are often not representative of genetic ancestry,
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especially in admixed populations such as African-American or Hispanic (Bild et al., 2002; Bryc
et al., 2015).
Overall, we identified 141 unique significant gene-trait pairs using the AFA and HIS
MESA transcriptome prediction models along with the PAGE GWAS summary statistics. Of
these gene-trait pairs, 11 were found to have colocalized GWAS and eQTL signals in COLOC
and were found to have replicated in a larger, European PhenomeXcan analysis. However, the
HIS model identified all 11 genes while the AFA only identified 3 of the 11 genes. This is likely
due to the size difference between the models (HIS n = 352, AFA n = 233) and that there are
more Hispanic/Latino individuals in PAGE than African-American individuals. Then, through
applying the larger AFHI, EUR, and ALL MESA transcriptome models along with the PAGE
GWAS summary statistics, we identified 240 unique gene-trait pairs using S-PrediXcan. Of these
significant gene-trait pairs, 17 were found to have colocalized eQTL and GWAS signals and
were replicated in PhenomeXcan. Of the five MESA transcriptome models, HIS returned the
highest rate of replication (41%); however, AFHI had the highest predictive power, discovering
32 colocalized, significant gene-trait pairs with a replication rate of 34%.
Between the S-PrediXcan significant, colocalized, and PhenomeXcan replicated genetrait pairs, only one was found to be significant across all five MESA transcriptome prediction
models: BAK1 in association with platelet count. 7 genes: CBL, ISCA2, RASA2, SMIM19,
TMEM258, CREB5, and PGAP3 were only identified by the AFHI, HIS, or AFA transcriptome
models. CREB5 and PGAP3 were unique to the HIS transcriptome prediction model.
Previously, many biobank-size resources contain only European individuals, creating a
significant gap in genomic understanding (Martin et al., 2019). While the GWAS summary
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statistics from the combined PAGE populations are currently available in the GWAS Catalog,
making within population summary statistics publicly available in future studies will encourage
meta-analyses and promote development of more sophisticated models to help narrow the
diversity gap in genomics (Peterson et al., 2019; Ben-Eghan et al., 2020). Overall, more
genomes and transcriptomes in more tissues in admixed populations are needed to enhance
model development and to better understand the genetics of complex traits in all populations.
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